[KongchangAI]
Concept嵌合抗原受体T细胞疗法

CAR-T

A cellular immunotherapy in which a patient's T cells are genetically engineered to express a chimeric antigen receptor, enabling them to specifically recognize and kill tumor cells.

Timeline (last 90 days)

Oct 30

Expert review judged 37 CAR-T hypotheses as both novel and biologically plausible.

Unverified50%

All Facts (1)

Source Articles